156 related articles for article (PubMed ID: 18716999)
1. Genome damage in oropharyngeal cancer patients treated by radiotherapy.
Gamulin M; Kopjar N; Grgić M; Ramić S; Bisof V; Garaj-Vrhovac V
Croat Med J; 2008 Aug; 49(4):515-27. PubMed ID: 18716999
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetic follow-up in testicular seminoma patients exposed to adjuvant radiotherapy.
Gamulin M; Kopjar N; Grgić M; Ramić S; Viculin T; Petković M; Garaj-Vrhovac V
Coll Antropol; 2010 Jun; 34(2):455-65. PubMed ID: 20698117
[TBL] [Abstract][Full Text] [Related]
3. DNA and cytogenetic damage in white blood cells of postmenopausal breast cancer patients treated with radiotherapy.
Gamulin M; Garaj-Vrhovac V; Kopjar N; Ramić S; Viculin T; Juretić A; Grgić M
J Environ Sci Health A Tox Hazard Subst Environ Eng; 2010; 45(3):292-304. PubMed ID: 20390870
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of DNA damage in radiotherapy-treated cancer patients using the alkaline comet assay.
Gamulin M; Garaj-Vrhovac V; Kopjar N
Coll Antropol; 2007 Sep; 31(3):837-45. PubMed ID: 18041397
[TBL] [Abstract][Full Text] [Related]
5. Study the impact of astaxanthin on developing of genomic instability in human peripheral blood lymphocytes irradiated in vitro on G2 phase of cell cycle.
Кurinnyi DA; Rushkovsky SR; Demchenko OM; Pilinska MA
Probl Radiac Med Radiobiol; 2017 Dec; 22():208-215. PubMed ID: 29286507
[TBL] [Abstract][Full Text] [Related]
6. Assessment of genotoxic risks in Croatian health care workers occupationally exposed to cytotoxic drugs: a multi-biomarker approach.
Kopjar N; Garaj-Vrhovac V; Kasuba V; Rozgaj R; Ramić S; Pavlica V; Zeljezić D
Int J Hyg Environ Health; 2009 Jul; 212(4):414-31. PubMed ID: 19049854
[TBL] [Abstract][Full Text] [Related]
7. Analysis of mandibular dose distribution in radiotherapy for oropharyngeal cancer: dosimetric and clinical results in 18 patients.
Jereczek-Fossa BA; Garibaldi C; Catalano G; d'Onofrio A; De Pas T; Bocci C; Ciocca M; DePaoli F; Orecchia R
Radiother Oncol; 2003 Jan; 66(1):49-56. PubMed ID: 12559520
[TBL] [Abstract][Full Text] [Related]
8. Measuring the genetic damage in cancer patients during radiotherapy with three genetic end-points.
Jianlin L; Jiliang H; Lifen J; Wei Z; Baohong W; Hongping D
Mutagenesis; 2004 Nov; 19(6):457-64. PubMed ID: 15548757
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic damage after 131-iodine treatment for hyperthyroidism and thyroid cancer. A study using the micronucleus test.
Gutiérrez S; Carbonell E; Galofré P; Creus A; Marcos R
Eur J Nucl Med; 1999 Dec; 26(12):1589-96. PubMed ID: 10638411
[TBL] [Abstract][Full Text] [Related]
10. CYTOGENETIC DAMAGES IN LUNG CANCER PATIENTS TREATED BY EXTERNAL RADIATION THERAPY.
Maznyk N; Sypko T; Starenkiy V; Bohatyrenko N; Bilozor N
Probl Radiac Med Radiobiol; 2019 Dec; 24():411-425. PubMed ID: 31841483
[TBL] [Abstract][Full Text] [Related]
11. Biodosimetry Based on γ-H2AX Quantification and Cytogenetics after Partial- and Total-Body Irradiation during Fractionated Radiotherapy.
Zahnreich S; Ebersberger A; Kaina B; Schmidberger H
Radiat Res; 2015 Apr; 183(4):432-46. PubMed ID: 25844946
[TBL] [Abstract][Full Text] [Related]
12. Risk assessment of oral cancer in patients with pre-cancerous states of the oral cavity using micronucleus test and challenge assay.
Saran R; Tiwari RK; Reddy PP; Ahuja YR
Oral Oncol; 2008 Apr; 44(4):354-60. PubMed ID: 17936677
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity to DNA-damage induction and chromosomal alterations in mucosa cells from patients with and without cancer of the oropharynx detected by a combination of Comet assay and fluorescence in situ hybridization.
Harréus UA; Kleinsasser NH; Zieger S; Wallner B; Reiter M; Schuller P; Berghaus A
Mutat Res; 2004 Oct; 563(2):131-8. PubMed ID: 15364279
[TBL] [Abstract][Full Text] [Related]
14. Alkaline comet assay study with breast cancer patients: evaluation of baseline and chemotherapy-induced DNA damage in non-target cells.
Kopjar N; Milas I; Garaj-Vrhovac V; Gamulin M
Clin Exp Med; 2006 Dec; 6(4):177-90. PubMed ID: 17191110
[TBL] [Abstract][Full Text] [Related]
15. Radiotoxicity after strontium-89 therapy for bone metastases using the micronucleus assay.
Watanabe N; Yokoyama K; Kinuya S; Shuke N; Shimizu M; Michigishi T; Tonami N; Seto H; Goodwin DA
J Nucl Med; 1998 Dec; 39(12):2077-9. PubMed ID: 9867144
[TBL] [Abstract][Full Text] [Related]
16. Application of cytogenetic endpoints and Comet assay on human lymphocytes treated with vincristine in vitro.
Kopjar N; Garaj-Vrhovac V
Neoplasma; 2000; 47(3):162-7. PubMed ID: 11043839
[TBL] [Abstract][Full Text] [Related]
17. Assessment of genome damage in a population of Croatian workers employed in pesticide production by chromosomal aberration analysis, micronucleus assay and Comet assay.
Garaj-Vrhovac V; Zeljezic D
J Appl Toxicol; 2002; 22(4):249-55. PubMed ID: 12210542
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of genome damage in subjects occupationally exposed to possible carcinogens.
Zeljezic D; Mladinic M; Kopjar N; Radulovic AH
Toxicol Ind Health; 2016 Sep; 32(9):1570-80. PubMed ID: 25653038
[TBL] [Abstract][Full Text] [Related]
19. Genome damage in testicular seminoma patients seven years after radiotherapy.
Fucic A; Gamulin M; Katic J; Milic M; Druzhinin V; Grgić M
Int J Radiat Biol; 2013 Nov; 89(11):928-33. PubMed ID: 23859470
[TBL] [Abstract][Full Text] [Related]
20. Genotoxic effects of radiotherapy and chemotherapy on circulating lymphocytes in patients with Hodgkin's disease.
Bilban-Jakopin C; Bilban M
Mutat Res; 2001 Oct; 497(1-2):81-8. PubMed ID: 11525910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
